|
|
Volumn 530, Issue 7591, 2016, Pages 389-390
|
|
Synthetic biology's first malaria drug meets market resistance
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTEMISININ;
ANTIMALARIAL AGENT;
ARTEMISININ DERIVATIVE;
DRUG INDUSTRY;
EDITORIAL;
HEALTH;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
ITALY;
MALARIA;
MEDICINE;
PRIORITY JOURNAL;
SYNTHETIC BIOLOGY;
ARTEMISIA ANNUA;
CHEMISTRY;
CROP;
DRUG COST;
ECONOMICS;
GROWTH, DEVELOPMENT AND AGING;
HUMAN;
STATISTICS AND NUMERICAL DATA;
SUPPLY AND DISTRIBUTION;
TRENDS;
ANTIMALARIALS;
ARTEMISIA ANNUA;
ARTEMISININS;
CROPS, AGRICULTURAL;
DRUG COSTS;
HUMANS;
MALARIA;
SYNTHETIC BIOLOGY;
|
|
EID: 84959422900
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/530390a Document Type: Editorial |
|
Times cited : (111)
|
|
References (0)
|